Integrator: How a Glitch in RNA Processing Extends a Worm's Life bioRxiv

Original: "Adulthood depletion of Integrator extends lifespan and healthspan via defective pre-mRNA processing"
b42w:2604.90001 · the paper's page · 2026-04-21 · CC BY 4.0 · 4 min
Switching off a single protein complex in adulthood triggers a cascade of errors in RNA maturation that paradoxically slows aging in a nematode.

Context

Aging comes with an accumulation of errors in gene expression, but which regulatory complexes actually set the pace of this process remains largely unclear. The Integrator complex is known as a key mediator of RNA polymerase II transcription: it terminates the synthesis of small noncoding RNAs and controls polymerase pausing. In the nematode Caenorhabditis elegans, a classic model in aging biology, this complex is essential for development, yet its role in the adult organism had never been studied. The work stands somewhat apart: the closest neighbors in the archive probe aging through DNA methylation, nuclear reactions, and proton therapy, but no one had linked Integrator to lifespan. The authors fill that gap, using the worm as a convenient system for switching off individual subunits in living animals.

Methods

The researchers knocked down Integrator subunit genes using RNA interference, starting either at the fourth larval stage or on the fourth day of adulthood, and measured lifespan and health metrics (locomotor activity, thermotolerance). To work out the mechanism, they mapped the binding sites of the catalytic subunit INTS-11 across the entire genome with ChIP-seq, then sequenced total RNA and small RNAs from old worms. To test the role of individual tissues, they used tissue-specific RNA interference. They also measured the proteome and tracked mitochondria in muscle cells with a fluorescent reporter.

Results

Of the 12 Integrator subunits tested, knocking down eight of them, including the catalytic INTS-11, extended the worms' lifespan. The effect was independent of reproduction: the extension persisted in sterile mutants and when the intervention began after the reproductive period. The strongest influence came from suppressing INTS-11 in the somatic gonad. At the molecular level, loss of INTS-11 caused widespread defects in transcription termination of small nuclear RNAs, including the splice-leader RNAs required for trans-splicing. This led to intron retention in 2631 genes, enriched for components of the spliceosome and nuclear transport. In the proteome of old worms, the concentration of 768 proteins dropped, among them mitochondrial proteins. Mitochondria in muscles took on a hyperfused morphology characteristic of stress adaptation. The key link turned out to be endogenous small RNAs 22 nucleotides long: in mutants lacking their biogenesis, the lifespan extension from INTS-11 knockdown vanished, and health even worsened.

Implications

The work is the first to show that postembryonic disruption of trans-splicing can extend lifespan, and that Integrator acts as a pleiotropic regulator of aging. Unlike neighboring studies that examine aging through epigenetics or cellular signaling pathways, this one uncovers a cascade running from transcription termination defects to mitochondrial dysfunction. It adds a new layer to our understanding of why the correlation between mRNA and protein during aging is often weak: trans-splicing may be an underappreciated regulator of translation. The results also caution against a simple interpretation in the spirit of antagonistic pleiotropy: the lifespan extension arises not from some harmful action of Integrator in old age, but from an adaptive response to the partial loss of its function.

Future development

The field could move toward figuring out exactly how 22G RNAs select their targets among improperly processed transcripts and which Argonaute proteins are involved. It would be interesting to test whether other known longevity mutations in worms act through modulation of trans-splicing. Translating this to mammals will require studying whether microRNAs or other pathways compensate for the absence of 22G RNAs when snRNP processing is disrupted in human cells.

Impact

The results will influence research in aging biology, post-transcriptional regulation, and small RNA biogenesis. They may also interest gerontologists looking for new targets to intervene in healthy longevity.

Next steps

Determine which Argonaute proteins and RNA-dependent RNA polymerases specifically mediate the 22G RNA effect. Investigate how knocking down different Integrator modules affects complex stability and the transcription profile in individual tissues.

Key open problems

The work speaks directly to an unsolved problem in aging biology: why the correlation between mRNA and protein levels during aging is often weak. A concrete mechanism is proposed, namely disrupted trans-splicing, which may explain part of the discrepancies. In addition, the paper contributes to a long-standing debate over which genes are true regulators of longevity and which merely trigger adaptive responses when switched off.

In the worm C. elegans, about 85% of genes undergo trans-splicing, in which a short leader exon from a separate RNA is stitched onto the start of the mRNA. Humans have no such mechanism, so directly transferring the results to people is difficult.

The idea that mild damage to cellular systems can extend life echoes the concept of hormesis, played out in Kim Stanley Robinson's novel Aurora: there, the crew of a starship faces the consequences of artificially slowing aging by manipulating cellular stress pathways.

Key numbers

  • lifespan extension: up to 20% in worms upon INTS-11 knockdown
  • genes with intron retention: 2631
  • length of small RNAs: 22 nucleotides
  • protein decrease in the proteome: 768 out of 845 differentially expressed
  • INTS-11 binding peaks: 7276 in the worm genome

Take the whole work

Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.

Concepts
inflammation neurodegeneration aging biological age epigenetic aging alzheimers disease telomerase